![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Emnar Pharma Private Limited Hyderabad In, based in India, is a pharmaceutical company.
One of their significant offerings is Levetiracetam, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2021-500 - Rev 01
This Chemical Type CEP, issued on October 27, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2535 associated with this CEP further emphasizes